| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |